Vijay Patel
Experienced in Vertigo

Dr. Vijay Patel

Sleep Medicine
Piedmont Healthcare
Piedmont Physicians Pulmonary And Sleep Medicine Newnan
2301 Newnan Crossing Boulevard, Suite 200, 
Newnan, GA 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth

Experienced in Vertigo
Piedmont Healthcare
Piedmont Physicians Pulmonary And Sleep Medicine Newnan
2301 Newnan Crossing Boulevard, Suite 200, 
Newnan, GA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Vijay M. Patel, MD, FCCP, earned his medical degree from the Southern Illinois University School of Medicine in Springfield, Illinois. He completed his internal medicine internship and residency at Emory University School of Medicine in Atlanta. Following his residency, Dr. Patel completed a pulmonary and critical care medicine fellowship and Emory University School of Medicine. Dr. Patel is board certified in pulmonary medicine and internal medicine. Prior to joining Piedmont Physicians Group, Dr. Patel was in practice at PAPP Clinic. His special interests include sleep disorders, asthma, emphysema, chronic bronchitis, lung disorder, bronchoscopy, thoracentesis and pulmonary function tests. Dr. Patel is a member of the American College of Physicians, the Society of Critical Care Medicine, the American College of Chest Physicians and the American Thoracic Society. In his spare time, Dr. Patel enjoys spending time with his family. Dr. Patel is accepting new patients and welcomes most major insurance plans.

Dr. Patel is rated as an Experienced provider by MediFind in the treatment of Vertigo. His top areas of expertise are Obstructive Sleep Apnea, Emphysema, Bullae, and Narcolepsy.

His clinical research consists of co-authoring 2 peer reviewed articles and participating in 17 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Southern Illinois University School Of Medicine, 1990
Residency
Emory University School of Medicine, Internal Medicine, 1993
Specialties
Sleep Medicine
Licenses
Internal Medicine in GA
Board Certifications
American Board Of Internal Medicine - Pulmonary Disease
American Board Of Internal Medicine - Sleep Medicine
Fellowships
Emory University School of Medicine, Pulmonary/Critical Care, 1996
Hospital Affiliations
Piedmont Newnan Hospital, Inc
Piedmont Hospital, Inc
Piedmont Fayette Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alliant Health
  • HMO
  • PPO
Ambetter
  • EPO
  • HMO
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareSource
  • HMO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
Friday Health

Accepted plan types not found. Please verify directly with the provider.

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
TeamCare
  • OTHER COMMERCIAL
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 21 Less Insurance Carriers -

Locations

Piedmont Physicians Pulmonary and Sleep Medicine Newnan
2301 Newnan Crossing Boulevard, Suite 200, Newnan, GA 30265
Call: 770-683-6921

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


14 Clinical Trials

Phase 1 / 2 Multicenter Study of the Safety, Pharmacokinetics, and Preliminary Efficacy of APL-101 in Subjects With Non-Small Cell Lung Cancer With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Phase 1 / 2 Multicenter Study of the Safety, Pharmacokinetics, and Preliminary Efficacy of APL-101 in Subjects With Non-Small Cell Lung Cancer With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
Enrollment Status: Recruiting
Publish Date: June 27, 2025
Intervention Type: Drug
Study Drug: APL-101
Study Phase: Phase 2
A Phase III, Multi-center, Open-label, Randomized Study of Oral Asciminib Versus Investigator Selected TKI in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase
A Phase III, Multi-center, Open-label, Randomized Study of Oral Asciminib Versus Investigator Selected TKI in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia in Chronic Phase
Enrollment Status: Active_not_recruiting
Publish Date: November 21, 2025
Intervention Type: Drug
Study Drugs: Imatinib, Nilotinib, Bosutinib, Dasatinib, Asciminib
Study Phase: Phase 3
A Phase 2, Randomized, Open-Label Study of Trilaciclib Administered With First-Line Platinum-Based Chemotherapy and Avelumab Maintenance Therapy in Patients With Untreated, Locally Advanced or Metastatic Urothelial Carcinoma (PRESERVE 3)
A Phase 2, Randomized, Open-Label Study of Trilaciclib Administered With First-Line Platinum-Based Chemotherapy and Avelumab Maintenance Therapy in Patients With Untreated, Locally Advanced or Metastatic Urothelial Carcinoma (PRESERVE 3)
Enrollment Status: Terminated
Publish Date: September 08, 2025
Intervention Type: Drug
Study Drugs: Trilaciclib, Gemcitabine, Cisplatin, Carboplatin, Avelumab
Study Phase: Phase 2
A Phase 2 Study to Evaluate the Safety and Efficacy of AB122 Monotherapy, AB154 in Combination With AB122, and AB154 in Combination With AB122 and AB928 in Front-Line, Non-Small Cell Lung Cancer
A Phase 2 Study to Evaluate the Safety and Efficacy of AB122 Monotherapy, AB154 in Combination With AB122, and AB154 in Combination With AB122 and AB928 in Front-Line, Non-Small Cell Lung Cancer
Enrollment Status: Completed
Publish Date: August 26, 2025
Intervention Type: Drug
Study Drugs: Zimberelimab, Domvanalimab, Etrumadenant
Study Phase: Phase 2
A Randomized, Double-blind, Placebo-Controlled, Active-Comparator, Multicenter, Phase 3 Study of Brentuximab Vedotin or Placebo in Combination With Lenalidomide and Rituximab in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
A Randomized, Double-blind, Placebo-Controlled, Active-Comparator, Multicenter, Phase 3 Study of Brentuximab Vedotin or Placebo in Combination With Lenalidomide and Rituximab in Subjects With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Enrollment Status: Active_not_recruiting
Publish Date: August 26, 2025
Intervention Type: Drug, Other
Study Drugs: Brentuximab vedotin, Rituximab, Lenalidomide
Study Phase: Phase 3
A Phase 1b/2, Open-Label, Randomized Platform Study Evaluating the Efficacy and Safety of AB928-Based Treatment Combinations in Patients With Metastatic Castrate Resistant Prostate Cancer
A Phase 1b/2, Open-Label, Randomized Platform Study Evaluating the Efficacy and Safety of AB928-Based Treatment Combinations in Patients With Metastatic Castrate Resistant Prostate Cancer
Enrollment Status: Completed
Publish Date: July 22, 2025
Intervention Type: Drug
Study Drugs: Etrumadenant, Zimberelimab, AB680, Enzalutamide, Docetaxel
Study Phase: Phase 1/Phase 2
An Open-label, Phase 2 Basket Study of SEA-CD40 Combination Therapies in Advanced Malignancies
An Open-label, Phase 2 Basket Study of SEA-CD40 Combination Therapies in Advanced Malignancies
Enrollment Status: Completed
Publish Date: May 11, 2025
Intervention Type: Drug
Study Drugs: SEA-CD40, Pembrolizumab, Pemetrexed, Carboplatin
Study Phase: Phase 2
A Randomized Prospective Trial of Adjuvant Chemotherapy in Patients With Completely Resected Stage I or IIA Non-Squamous Non-Small Cell Lung Cancer Identified as Intermediate or High Risk by a 14-Gene Prognostic Assay
A Randomized Prospective Trial of Adjuvant Chemotherapy in Patients With Completely Resected Stage I or IIA Non-Squamous Non-Small Cell Lung Cancer Identified as Intermediate or High Risk by a 14-Gene Prognostic Assay
Enrollment Status: Active_not_recruiting
Publish Date: April 13, 2025
Intervention Type: Drug, Other
Study Drug: Adjuvant Chemotherapy
Study Phase: Not Applicable
A Global Multicenter Randomized Placebo-Controlled Phase 3 Trial To Compare The Efficacy And Safety Of Fruquintinib Plus Best Supportive Care To Placebo Plus Best Supportive Care In Patients With Refractory Metastatic Colorectal Cancer
A Global Multicenter Randomized Placebo-Controlled Phase 3 Trial To Compare The Efficacy And Safety Of Fruquintinib Plus Best Supportive Care To Placebo Plus Best Supportive Care In Patients With Refractory Metastatic Colorectal Cancer
Enrollment Status: Completed
Publish Date: April 04, 2025
Intervention Type: Drug
Study Drug: Fruquintinib
Study Phase: Phase 3
MOUNTAINEER: A Phase II, Open Label Study of Tucatinib Combined With Trastuzumab in Patients With HER2+ Metastatic Colorectal Cancer
MOUNTAINEER: A Phase II, Open Label Study of Tucatinib Combined With Trastuzumab in Patients With HER2+ Metastatic Colorectal Cancer
Enrollment Status: Completed
Publish Date: November 26, 2024
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Open-label, Single-arm Phase II Study to Evaluate Anti-tumor Efficacy and Safety of NT-I7 in Combination With Atezolizumab in Subjects With Previously Untreated, PD-L1-expressing, Locally Advanced or Metastatic NSCLC
A Multicenter, Open-label, Single-arm Phase II Study to Evaluate Anti-tumor Efficacy and Safety of NT-I7 in Combination With Atezolizumab in Subjects With Previously Untreated, PD-L1-expressing, Locally Advanced or Metastatic NSCLC
Enrollment Status: Active_not_recruiting
Publish Date: March 05, 2024
Intervention Type: Drug
Study Drugs: Efineptakin alfa, Atezolizumab
Study Phase: Phase 2
An Open-Label, Multicenter, Phase 2 Study of the Safety and Efficacy of KRT-232 in Subjects With Relapsed or Refractory Small Cell Lung Cancer (SCLC)
An Open-Label, Multicenter, Phase 2 Study of the Safety and Efficacy of KRT-232 in Subjects With Relapsed or Refractory Small Cell Lung Cancer (SCLC)
Enrollment Status: Terminated
Publish Date: August 16, 2023
Intervention Type: Drug
Study Drug: KRT-232
Study Phase: Phase 2
A Phase 2 Randomized, Multicenter, Double-Blind Study of the Glutaminase Inhibitor Telaglenastat With Pembrolizumab and Chemotherapy Versus Placebo With Pembrolizumab and Chemotherapy in First-Line, Metastatic KEAP1/NRF2-Mutated, Nonsquamous, Non-Small Cell Lung Cancer (NSCLC)
A Phase 2 Randomized, Multicenter, Double-Blind Study of the Glutaminase Inhibitor Telaglenastat With Pembrolizumab and Chemotherapy Versus Placebo With Pembrolizumab and Chemotherapy in First-Line, Metastatic KEAP1/NRF2-Mutated, Nonsquamous, Non-Small Cell Lung Cancer (NSCLC)
Enrollment Status: Terminated
Publish Date: September 21, 2022
Intervention Type: Drug, Dietary supplement, Biological
Study Drugs: Telaglenastat, Carboplatin Chemotherapy, Pemetrexed Chemotherapy, Pembrolizumab Immunotherapy, Dexamethasone
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing CB-839 in Combination With Everolimus (CBE) vs. Placebo With Everolimus (PboE) in Patients With Advanced or Metastatic Renal Cell Carcinoma (RCC)
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing CB-839 in Combination With Everolimus (CBE) vs. Placebo With Everolimus (PboE) in Patients With Advanced or Metastatic Renal Cell Carcinoma (RCC)
Enrollment Status: Completed
Publish Date: September 15, 2022
Intervention Type: Drug
Study Phase: Phase 2
View 13 Less Clinical Trials

2 Total Publications

Large B-cell Lymphoma With Interferon Regulatory Factor 4 Rearrangement Presenting as a Primary Central Nervous System Lymphoma in the Brain.
Large B-cell Lymphoma With Interferon Regulatory Factor 4 Rearrangement Presenting as a Primary Central Nervous System Lymphoma in the Brain.
Journal: Cureus
Published: May 07, 2025
View All 2 Publications
Similar Doctors
Tarsem L. Gupta
Advanced in Vertigo
Dr. Tarsem L. Gupta
Sleep Medicine
Advanced in Vertigo
Dr. Tarsem L. Gupta
Sleep Medicine

Atlanta Pulmonary Care And Sleep Solutions

245 Village Center Parkway, Suite 100, 
Stockbridge, GA 
 (35.5 miles away)
770-506-7171
Languages Spoken:
English, Hindi
See accepted insurances
Accepting New Patients
Offers Telehealth

Tarsem Gupta is a Sleep Medicine provider in Stockbridge, Georgia. Dr. Gupta is rated as a Distinguished provider by MediFind in the treatment of Vertigo. His top areas of expertise are Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Obstructive Sleep Apnea, and Chronic Cough. Dr. Gupta is currently accepting new patients.

Advanced in Vertigo
Dr. Badar H. Syed
Neurology | Sleep Medicine
Advanced in Vertigo
Dr. Badar H. Syed
Neurology | Sleep Medicine

Gwinnett Neurology And Sleep Disorders Clinic

2331 Henry Clower Boulevard, Suite A, 
Snellville, GA 
 (54.9 miles away)
770-972-3002
Languages Spoken:
English, Urdu
See accepted insurances
Accepting New Patients
Offers Telehealth

Badar Syed is a Neurologist and a Sleep Medicine provider in Snellville, Georgia. Dr. Syed is rated as a Distinguished provider by MediFind in the treatment of Vertigo. His top areas of expertise are Primary Orthostatic Tremor, Memory Loss, Autosomal Dominant Partial Epilepsy with Auditory Features, and Alzheimer's Disease. Dr. Syed is currently accepting new patients.

Kenneth J. Lazarus
Advanced in Vertigo
Dr. Kenneth J. Lazarus
Neurology | Pain Medicine | Sleep Medicine
Advanced in Vertigo
Dr. Kenneth J. Lazarus
Neurology | Pain Medicine | Sleep Medicine

Southern Crescent Neurological Clinic

1250 Highway 54 West, Suite 102, 
Fayetteville, GA 
 (18.0 miles away)
770-719-2965
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Kenneth Lazarus is a Neurologist and a Pain Medicine provider in Fayetteville, Georgia. Dr. Lazarus is rated as a Distinguished provider by MediFind in the treatment of Vertigo. His top areas of expertise are Migraine, Epilepsy, Memory Loss, and Fibromyalgia. Dr. Lazarus is currently accepting new patients.

VIEW MORE VERTIGO DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Patel's expertise for a condition
ConditionClose
    • Distinguished
    • Acute Interstitial Pneumonia
      Dr. Patel is
      Distinguished
      . Learn about Acute Interstitial Pneumonia.
      See more Acute Interstitial Pneumonia experts
    • Bronchiectasis
      Dr. Patel is
      Distinguished
      . Learn about Bronchiectasis.
      See more Bronchiectasis experts
    • Bronchitis
      Dr. Patel is
      Distinguished
      . Learn about Bronchitis.
      See more Bronchitis experts
    • Bullae
      Dr. Patel is
      Distinguished
      . Learn about Bullae.
      See more Bullae experts
    • Emphysema
      Dr. Patel is
      Distinguished
      . Learn about Emphysema.
      See more Emphysema experts
    • Lung Metastases
      Dr. Patel is
      Distinguished
      . Learn about Lung Metastases.
      See more Lung Metastases experts
    View All 8 Distinguished Conditions
    • Advanced
    • Acatalasemia
      Dr. Patel is
      Advanced
      . Learn about Acatalasemia.
      See more Acatalasemia experts
    • Asthma
      Dr. Patel is
      Advanced
      . Learn about Asthma.
      See more Asthma experts
    • Atypical Pneumonia
      Dr. Patel is
      Advanced
      . Learn about Atypical Pneumonia.
      See more Atypical Pneumonia experts
    • Bronchiolitis Obliterans
      Dr. Patel is
      Advanced
      . Learn about Bronchiolitis Obliterans.
      See more Bronchiolitis Obliterans experts
    • Bronchogenic Cyst
      Dr. Patel is
      Advanced
      . Learn about Bronchogenic Cyst.
      See more Bronchogenic Cyst experts
    • Central Sleep Apnea
      Dr. Patel is
      Advanced
      . Learn about Central Sleep Apnea.
      See more Central Sleep Apnea experts
    View All 29 Advanced Conditions
    • Experienced
    • Acquired Tracheomalacia
      Dr. Patel is
      Experienced
      . Learn about Acquired Tracheomalacia.
      See more Acquired Tracheomalacia experts
    • ALK-Positive Non-Small Cell Lung Cancer
      Dr. Patel is
      Experienced
      . Learn about ALK-Positive Non-Small Cell Lung Cancer.
      See more ALK-Positive Non-Small Cell Lung Cancer experts
    • Alpha-1 Antitrypsin Deficiency (AATD)
      Dr. Patel is
      Experienced
      . Learn about Alpha-1 Antitrypsin Deficiency (AATD).
      See more Alpha-1 Antitrypsin Deficiency (AATD) experts
    • Asbestosis
      Dr. Patel is
      Experienced
      . Learn about Asbestosis.
      See more Asbestosis experts
    • Asthma in Children
      Dr. Patel is
      Experienced
      . Learn about Asthma in Children.
      See more Asthma in Children experts
    • Cholesterol Pneumonia
      Dr. Patel is
      Experienced
      . Learn about Cholesterol Pneumonia.
      See more Cholesterol Pneumonia experts
    View All 33 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.